Tower Research Capital (TRC)’s Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant ACII.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9
Closed 6825
2022
Q3
$0 Hold
9
﹤0.01% 6854
2022
Q2
$0 Hold
9
﹤0.01% 6934
2022
Q1
$0 Hold
9
﹤0.01% 7007
2021
Q4
$0 Buy
+9
New +$90 ﹤0.01% 6893

Tower Research Capital (TRC)'s ACII.U Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant (ACII.U) in Q4 2022, closing a stake of 9 shares.

Tower Research Capital (TRC) first reported a position in ACII.U in Q4 2021 and held it in 4 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold ACII.U as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 9 Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant shares in Q4 2022.
  • Tower Research Capital (TRC) first reported a position in Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant in Q4 2021 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant position peaked at $0 in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.